THE MOLECULAR-BIOLOGY OF ESOPHAGEAL AND GASTRIC-CANCER AND THEIR PRECURSORS - ONCOGENES, TUMOR-SUPPRESSOR GENES, AND GROWTH-FACTORS

被引:113
作者
STEMMERMANN, G [1 ]
HEFFELFINGER, SC [1 ]
NOFFSINGER, A [1 ]
HUI, YZ [1 ]
MILLER, MA [1 ]
FENOGLIOPREISER, CM [1 ]
机构
[1] UNIV CINCINNATI,COLL MED,DEPT PATHOL & LAB MED,CINCINNATI,OH 45267
关键词
ESOPHAGEAL CANCER; GASTRIC CANCER; ONCOGENES; TUMOR SUPPRESSOR GENES; GROWTH FACTORS; P5S;
D O I
10.1016/0046-8177(94)90056-6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The evolution of sequential histological changes from normal cells through invasive cancer affords the cancer biologist the opportunity to identify separate molecular steps involved in cancer progression. As one studies the development of human carcinoma, it becomes apparent that multiple genetic alterations affecting both cellular proto-oncognes and tumor suppressor genes are involved during the development and progression of both esophageal and gastric cancers. The different histological forms of both esophageal and gastric carcinomas as well as their differing etiologies result in the possibility that a spectrum of genetic changes is involved in different tumor types. p53 abnormalities occur frequently in tumors arising in both organs, and in both sites p53 abnormalities can be observed in precancerous lesions as well as in overt cancer. Subsequent abnormalities affecting other genes (ep; epithelial growth factor receptors [EGFRs]) potentially enhance the growth potential of tumors. This review focuses on abnormalities of oncogenes, tumor suppressor gems, and growth factors commonly found in cancers of the esophapus and stomach. Copyright (C) 1994 by W.B. Saunders Company
引用
收藏
页码:968 / 981
页数:14
相关论文
共 173 条
[11]  
BERENSON JR, 1989, ONCOGENE, V4, P1111
[12]  
BLOUNT PL, 1991, CANCER RES, V51, P4582
[13]   LOSS OF HETEROZYGOSITY INVOLVING THE APC AND MCC GENETIC-LOCI OCCURS IN THE MAJORITY OF HUMAN ESOPHAGEAL CANCERS [J].
BOYNTON, RF ;
BLOUNT, PL ;
YIN, J ;
BROWN, VL ;
HUANG, Y ;
TONG, Y ;
MCDANIEL, T ;
NEWKIRK, C ;
RESAU, JH ;
RASKIND, WH ;
HAGGITT, RC ;
REID, BJ ;
MELTZER, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) :3385-3388
[14]   TRANSMEMBRANE TGF-ALPHA PRECURSORS ACTIVATE EGF TGF-ALPHA RECEPTORS [J].
BRACHMANN, R ;
LINDQUIST, PB ;
NAGASHIMA, M ;
KOHR, W ;
LIPARI, T ;
NAPIER, M ;
DERYNCK, R .
CELL, 1989, 56 (04) :691-700
[15]   IMMUNOHISTOCHEMICAL ANALYSIS OF RAS ONCOGENE-P21 PRODUCT IN HUMAN GASTRIC CARCINOMAS AND THEIR ADJACENT MUCOSAS [J].
CARNEIRO, F ;
DAVID, L ;
SUNKEL, C ;
LOPES, C ;
SOBRINHOSIMOES, M .
PATHOLOGY RESEARCH AND PRACTICE, 1992, 188 (03) :263-272
[16]   SEGREGATION ANALYSIS OF ESOPHAGEAL CANCER IN 221 HIGH-RISK CHINESE FAMILIES [J].
CARTER, CL ;
HU, N ;
WU, M ;
LIN, PZ ;
MURIGANDE, C ;
BONNEY, GE .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (10) :771-776
[17]   CHARACTERIZATION AND CHROMOSOME ASSIGNMENT OF THE HUMAN HOMOLOG OF INT-2, A POTENTIAL PROTOONCOGENE [J].
CASEY, G ;
SMITH, R ;
MCGILLIVRAY, D ;
PETERS, G ;
DICKSON, C .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (02) :502-510
[18]  
CASSON AG, 1991, CANCER RES, V51, P4495
[19]  
COHEN JA, 1989, ONCOGENE, V4, P81
[20]  
COHEN S, 1982, J BIOL CHEM, V257, P1523